Tonix Pharmaceuticals (TNXP) Earnings Date, Estimates & Call Transcripts $0.19 +0.00 (+0.47%) (As of 01:58 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Tonix Pharmaceuticals Latest Earnings SummaryUpcoming Earnings DateApr. 7EstimatedActual EPS (Nov. 12) -$0.23 Beat By $1.80 Consensus EPS (Nov. 12) -$2.03 Tonix Pharmaceuticals issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.23, which topped the consensus estimate of -$2.03 by $1.80. Quarterly revenue was reported to be $2.82 million, above analysts' expectations of $2.63 million. With a trailing EPS of -$52.74, Tonix Pharmaceuticals' earnings are expected to grow next year, from ($18.00) to ($5.54) per share. TNXP Upcoming EarningsTonix Pharmaceuticals' next earnings date is estimated for Monday, April 7, 2025, based off prior year's reporting schedules. Get Tonix Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tonix Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTNXP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TNXP Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Tonix Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.31-$0.31-$0.31Q2 20241-$0.29-$0.29-$0.29Q3 20241-$0.27-$0.27-$0.27Q4 20241-$0.25-$0.25-$0.25FY 20244($1.12)($1.12)($1.12) Tonix Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 4/7/2025(Estimated)------- 11/12/2024--$2.03-$0.23+$1.80-$0.23$2.63M$2.82M8/16/2024--$9.91-$19.28 -$9.37-$19.28$3.50M$2.21M5/13/2024Q1 2024-$16.64-$5.76+$10.88-$0.18$4.00M$2.48M4/1/2024Q4 2023--$27.52 -$27.52-$0.86$3.95M$3.78M11/9/2023Q3 2023-$47.68-$58.56 -$10.88-$1.83$5.80M$3.99M8/10/2023Q2 2023-$88.96-$85.76+$3.20-$2.68--Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link.5/8/2023Q1 2023-$80.00-$104.00 -$24.00-$3.25--3/13/2023Q4 2022-$172.00-$112.00+$60.00-$0.56-- Tonix Pharmaceuticals Earnings - Frequently Asked Questions When is Tonix Pharmaceuticals's earnings date? Tonix Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 7th, 2025 based off last year's report dates. Learn more on TNXP's earnings history. Did Tonix Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Tonix Pharmaceuticals (NASDAQ:TNXP) reported ($0.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.03) by $1.80. Learn more on analysts' earnings estimate vs. TNXP's actual earnings. How much revenue does Tonix Pharmaceuticals generate each year? Tonix Pharmaceuticals (NASDAQ:TNXP) has a recorded annual revenue of $7.77 million. How much profit does Tonix Pharmaceuticals generate each year? Tonix Pharmaceuticals (NASDAQ:TNXP) has a recorded net income of -$116.66 million. TNXP has generated -$52.74 earnings per share over the last four quarters. What is Tonix Pharmaceuticals's EPS forecast for next year? Tonix Pharmaceuticals's earnings are expected to grow from ($18.00) per share to ($5.54) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies VTYX Earnings VXRT Earnings ELUT Earnings CDTX Earnings TELO Earnings ADVM Earnings IFRX Earnings CRDF Earnings CGEN Earnings SKYE Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. This page (NASDAQ:TNXP) was last updated on 11/25/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
